Products

20-(tert-butoxy)-20-oxoicosanoic acid

CAS:683239-16-9

Quantity:

DMF Num:683239-16-9

Basic information

CAS NO. 683239-16-9
Purity ≥98%
English name 20-(tert-Butoxy)-20-oxoicosanoic acid
Molecular formula C24H46O4
Molecular weight 398.62
Storage conditions Room temperature storage
Character solid

Description

Key Features

Long-Alkyl Chain Protection:tert-Butoxycarbonyl (Boc) group on the 20th carbon enables orthogonal deprotection in insulin analog synthesis.

C20 Fatty Acid Backbone:Linear alkyl chain with terminal carboxylic acid, ideal for lipid-peptide conjugation in long-acting insulin development.

High Purity Profile:Single impurity ≤0.3%, total impurities ≤1.0% (COA with HPLC/GC-MS/FT-IR data available).

 

Applications

Insulin Icodec Side Chain Modification:

Critical for introducing the C20 fatty acid moiety in Insulin Icodec, extending half-life to 7 days via albumin binding.

Enables site-specific conjugation at LysB29, improving bolic stability by 400% compared to unmodified insulin.

Long-Acting Insulin Development:

Used in synthesizing basal insulin analogs (e.g., degludec) for type 1/2 diabetes, reducing dosing frequency to once weekly.

Lipid chain facilitates self-association into multihexamers, enabling sustained subcutaneous release.

Peptide-Lipid Conjugate Research:

Models for developing fatty acid-conjugated peptides with enhanced cellular uptake and blood-brain barrier permeability.

 

Manufacturing Standards

GMP-Compliant Facility:Produced in ISO 9001:2015 & ISO 14001 certified plant with 100% batch QC, including chiral purity analysis.

Global Regulatory Support:Provides DMF, CE, REACH, and US FDA documentation for clinical-stage projects.

Stability Testing:Validated for 24 months at room temperature, with no degradation under accelerated conditions (40°C, 75% RH for 14 days).

 

Analytical Data

683239-16-9 HNMR

683239-16-9 LCMS

 

Services Offered

Structural Modifications:

Alternative alkyl chains (C18-C22), isotopic labeling (¹³C, ²H) for PK/PD studies.

Custom protection groups (Boc, Cbz) for orthogonal deprotection strategies.

Scalable Production:

100 g to 10 kg batches, with process validation for GMP-grade materials (≥98.5% purity).

Technical Consultation:

Free synthetic route optimization by our PhD-level organic chemistry team (24-hour response).

 

Company Profile

15+ Years Experience:Specialized in peptide intermediates for global pharma and biotech industries.

R&D Capability:30+ scientists in a 2,000㎡ state-of-the-art laboratory.

Global FootprintServed 500+ clients in 30+ countries, including top 10 global pharma companies.

 

Contact Us

Email:export@pu-kang.com

Phone:+86-137-0808-4407

Address:Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.